Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243384 | SCV001416540 | uncertain significance | not provided | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with serine at codon 11 of the HOGA1 protein (p.Arg11Ser). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and serine. This variant is present in population databases (rs778696295, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with HOGA1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001829028 | SCV002791042 | uncertain significance | Primary hyperoxaluria type 3 | 2022-03-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001829028 | SCV002091543 | uncertain significance | Primary hyperoxaluria type 3 | 2020-03-18 | no assertion criteria provided | clinical testing |